Author:
Hofmann Guenter,Bauernhofer Thomas,Krippl Peter,Lang-Loidolt Doris,Horn Sabine,Goessler Walter,Schippinger Walter,Ploner Ferdinand,Stoeger Herbert,Samonigg Hellmut
Abstract
Abstract
Background
Cisplatin is widely used as an antineoplastic agent since it is effective against a broad spectrum of different tumours. Nevertheless, it has several potential side effects affecting different organ systems and an overdose may lead to life-threatening complications and even death.
Case presentation
We report on a 46-year old woman with non-small cell lung cancer who accidentally received 225 mg/m2 of cisplatin, which was threefold the dose as scheduled, within a 3-day period. Two days later, the patient presented with hearing loss, severe nausea and vomiting, acute renal failure as well as elevated liver enzymes. In addition, she developed a severe myelodepression. After plasmapheresis on two consecutive days and vigorous supportive treatment, the toxicity-related symptoms improved and the patient recovered without any sequelae.
Conclusion
To date, no general accepted guidelines for the treatment of cisplatin overdoses are available. Along with the experience from other published cases, our report shows that plasmapheresis is capable of lowering cisplatin plasma and serum levels efficiently. Therefore, plasma exchange performed as soon as possible can ameliorate all side effects of a cisplatin overdose and be a potential tool for clinicians for treatment. However, additional intensive supportive treatment-modalities are necessary to control all occurring side effects.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference25 articles.
1. Markman M: Toxicities of the platinum antineoplastic agents. Expert Opin Drug Saf. 2003, 2 (6): 597-607. 10.1517/14740338.2.6.597.
2. Hartmann JT, Lipp HP: Toxicity of platinum compounds. Expert Opin Pharmacother. 2003, 4 (6): 889-901. 10.1517/14656566.4.6.889.
3. Pike IM, Arbus MH: Cisplatin overdosage. J Clin Oncol. 1992, 10 (9): 1503-1504.
4. Blakley BW, Cohen JI, Doolittle ND, Muldoon LL, Campbell KC, Dickey DT, Neuwelt EA: Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001. Laryngoscope. 2002, 112 (11): 1997-2001. 10.1097/00005537-200211000-00016.
5. Chen CS, Seidel K, Armitage JO, Fay JW, Appelbaum FR, Horowitz MM, Shpall EJ, Weiden PL, Antman KS, Champlin RE, Kersey JH, Sullivan KM: Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 1997, 3 (6): 331-340.
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献